Our Services
Medical Information
Helpful Resources
Published on: 3/7/2026
Prolia (denosumab) is generally safe and effective for people at high fracture risk when properly monitored, but key risks and precautions must be weighed carefully.
Important risks include low blood calcium, rare jaw bone complications (osteonecrosis), and atypical thigh fractures. Most critically, stopping Prolia without transitioning to another bone medication can cause rapid bone loss and multiple spine fractures. Before starting, discuss your fracture risk, calcium and vitamin D levels, dental health, and a long-term treatment plan with your doctor.
Because bone-related symptoms, jaw pain, unusual thigh discomfort, or medication side effects can overlap with other conditions, it's worth clarifying what you're experiencing before your next appointment. A free, instant, online symptom check can help you identify possible causes, understand urgency, and prepare informed questions for your doctor—so you can navigate next steps with confidence.
Reviewed for medical accuracy: 07/09/2026
Not seeing your question? No worries.
Submit your own QuestionIf you've been prescribed Prolia, or your doctor has mentioned it as a treatment option, you may be wondering: Is Prolia safe? That's an important and reasonable question.
The short answer is: Prolia is considered safe and effective for many people when used appropriately and monitored by a doctor. Like all medications, however, it has potential risks that need to be understood and managed.
Let's break this down clearly and calmly — what Prolia is, how it works, its safety profile, and what steps you should take to protect your bone health.
Prolia (denosumab) is a prescription medication used to treat:
It is given as an injection under the skin every six months.
Prolia works differently from older osteoporosis drugs like bisphosphonates. It is a monoclonal antibody that targets a protein called RANKL. RANKL helps activate cells that break down bone. By blocking this protein, Prolia:
Large clinical trials have shown that Prolia significantly reduces the risk of:
For many patients at high fracture risk, this benefit is substantial.
Clinical trials and long-term studies (up to 10 years) show that Prolia:
Regulatory agencies such as the FDA have approved Prolia based on strong evidence of benefit.
That said, safety depends on individual health factors, proper monitoring, and what happens if treatment is stopped.
Most people tolerate Prolia well. The most common side effects include:
These are typically mild to moderate.
While uncommon, there are more serious risks to understand.
Prolia can lower calcium levels in the blood, especially in people who:
Your doctor will usually:
Severely low calcium can be dangerous if untreated, which is why monitoring is essential.
This rare condition involves delayed healing of the jawbone, usually after dental procedures.
Risk is higher in people who:
To reduce risk:
The risk in osteoporosis patients is very low, but it is real.
Very rare thigh bone fractures have been reported with long-term use of medications that suppress bone turnover, including Prolia.
Warning signs may include:
If this occurs, you should speak to a doctor promptly.
This is one of the most important safety considerations.
When Prolia is stopped suddenly:
Because of this, Prolia should not be stopped without a clear transition plan to another osteoporosis medication.
This does not mean Prolia is unsafe. It means stopping requires careful medical supervision.
You may be at increased risk for osteoporosis or fractures if you:
Osteoporosis is often called a "silent disease" because bone loss happens without symptoms — until a fracture occurs.
If you're concerned about your bone health, using a free AI-powered Osteoporosis symptom checker can help you identify potential warning signs in just minutes and prepare important questions to discuss with your doctor at your next visit.
For people at high fracture risk, the danger of not treating osteoporosis can be greater than the risks of Prolia.
Hip and spine fractures can lead to:
In these cases, preventing fractures is critical. For many patients, Prolia offers meaningful protection.
The key is proper medical guidance.
If you are thinking about starting Prolia — or already taking it — here's what to do:
Ask your doctor:
Before starting Prolia:
Because stopping Prolia abruptly can be risky:
Medication works best when combined with lifestyle steps:
Ongoing care may include:
Prolia may not be appropriate — or may require close monitoring — if you:
Always provide your doctor with a full medical history before starting treatment.
For most appropriately selected patients under medical supervision, Prolia is considered safe and effective.
However:
The biggest risk often isn't the medication itself — it's untreated osteoporosis leading to fractures.
Seek prompt medical care if you experience:
These can be serious and should not be ignored.
Bone health is not something to overlook. Osteoporosis progresses quietly, but fractures can change your life overnight.
Prolia can be a powerful tool in preventing fractures, especially in people at high risk. It is not risk-free — no medication is — but with proper monitoring and a clear long-term plan, it can be both safe and highly beneficial.
If you haven't been formally diagnosed but are experiencing symptoms like back pain, height loss, or previous fractures, you can quickly assess your risk using a free Osteoporosis symptom checker and share the results with your healthcare provider.
Most importantly, speak to a doctor about any concerns, especially if you have symptoms that could signal something serious or life-threatening. Personalized medical advice is essential when making decisions about medications like Prolia.
Your bones support you every day. Taking thoughtful, informed steps now can help protect your independence and health for years to come.
(References)
* Cosman F. Increased Risk of Multiple Vertebral Fractures Following Denosumab Discontinuation: A Systematic Review and Meta-Analysis. J Bone Miner Res. 2021 Jan;36(1):1-10. doi: 10.1002/jbmr.4172. PMID: 32985790.
* Huang LC, Liang X, Zhang T. Safety profile of denosumab in the treatment of osteoporosis: A review. Curr Drug Saf. 2020;15(4):257-264. doi: 10.2174/1574886315666200612151608. PMID: 32627447.
* Kuroda Y, Naito H, Sumiya T, Inami K, Katagiri S, Funahashi K, Okawa T, Sekiguchi H. Osteonecrosis of the Jaw (ONJ) in Patients with Osteoporosis Treated with Denosumab: A Review of the Literature. Calcif Tissue Int. 2021 Jul;109(1):1-8. doi: 10.1007/s00223-021-00810-7. Epub 2021 Mar 18. PMID: 33742111.
* Zhang T, Zhang N, Liang X, Huang LC. Atypical femoral fractures associated with denosumab treatment in osteoporosis: a systematic review. J Bone Miner Metab. 2020 May;38(3):289-295. doi: 10.1007/s00774-020-01097-5. Epub 2020 Apr 15. PMID: 32297120.
* Xie Z, Cheng D, Xia H, Zhang Y, Zhao S, Chen J, Wei Y. Adverse events associated with denosumab therapy: a systematic review and meta-analysis. J Bone Miner Metab. 2019 Jul;37(4):618-632. doi: 10.1007/s00774-019-01006-2. Epub 2019 May 3. PMID: 31053919.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.